Back

Potential biases arising from epidemic dynamics in observational seroprotection studies

2020-05-06 infectious diseases Title + abstract only
View on medRxiv
Show abstract

The extent and duration of immunity following SARS-CoV-2 infection are critical outstanding questions about the epidemiology of this novel virus, and studies are needed to evaluate the effects of serostatus on reinfection. Understanding the potential sources of bias and methods to alleviate biases in these studies is important for informing their design and analysis. Confounding by individual-level risk factors in observational studies like these is relatively well appreciated. Here, we show how...

Predicted journal destinations

1
Nature Communications
483 training papers
Top 6% 13.7%
2
Epidemiology
26 training papers
#1 7.3%
3
PLOS ONE
1737 training papers
Top 69% 7.3%
4
Clinical Infectious Diseases
219 training papers
Top 5% 6.0%
5
Scientific Reports
701 training papers
Top 51% 5.6%
6
PLOS Computational Biology
141 training papers
Top 3% 5.6%
7
Proceedings of the National Academy of Sciences
100 training papers
Top 1% 5.6%
8
eLife
262 training papers
Top 14% 3.6%
9
Nature Medicine
88 training papers
Top 1% 3.6%
10
Science
46 training papers
Top 1% 2.6%
11
The Journal of Infectious Diseases
137 training papers
Top 5% 2.6%
12
American Journal of Epidemiology
54 training papers
Top 2% 2.6%
13
Journal of The Royal Society Interface
54 training papers
Top 2% 2.6%
14
Epidemics
96 training papers
Top 5% 2.0%
15
Emerging Infectious Diseases
84 training papers
Top 6% 1.8%
16
BMC Medicine
155 training papers
Top 14% 1.8%
17
JAMA Network Open
125 training papers
Top 15% 1.4%
18
Science Advances
52 training papers
Top 2% 1.3%
19
The Lancet Infectious Diseases
57 training papers
Top 5% 1.1%
20
Nature
58 training papers
Top 6% 1.1%
21
JCI Insight
63 training papers
Top 7% 0.9%
22
BMC Infectious Diseases
110 training papers
Top 23% 0.9%
23
Open Forum Infectious Diseases
124 training papers
Top 14% 0.9%
24
International Journal of Infectious Diseases
115 training papers
Top 21% 0.9%
25
Science Translational Medicine
40 training papers
Top 5% 0.7%
26
PLOS Pathogens
35 training papers
Top 4% 0.7%